EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cognitive impairment and p‐tau217 are high in a vascular patient cohort

Scott R French iD, Juan C Arias, Summan Zahra, Madeline Ally, Cris Escareno, Emma Heitkamp, Franchell Vazquez, Madison Hillis, Haley Wiskoski, Karthik Ainapurapu, Gavin Culwell, Caronae Howell und 21 weitere

Alzheimer's & Dementia · 2025

DOI: 10.1002/alz.70565 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Scott R French und 32 weiteren Autor:innen. Beteiligte Einrichtung: The Division of Vascular Surgery, University of Arizona, Tucson, Arizona, USA. Hauptthemen laut MEDLINE: Cognitive Dysfunction, tau Proteins, Alzheimer Disease, Cardiovascular Diseases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Sciences, University of Arizona, U24 AG082930 Alzheimer Diagnosis in older Adults with Chronic Conditions ADACC Network, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Vascular comorbidities are modifiable contributors to cognitive impairment and Alzheimer's disease (AD), yet brain health outcomes are rarely evaluated in cardiovascular patients. METHODS This study prospectively evaluated cognition and AD pathology in 162 community‐dwelling adults with asymptomatic cardiovascular disease who did not have a clinical diagnosis of dementia or cognitive impairment. RESULTS Twenty‐nine percent of the cohort had Montreal Cognitive Assessment (MoCA) scores indicative of cognitive impairment or dementia after adjusting for age, sex, and education based on National Alzheimer's Coordinating Center normative data. AD blood biomarker phosphorylated tau217 was elevated in 55% of the cohort, significantly associated with decreased MoCA scores ( β = −1.46, 95% confidence interval [CI] −2.53 to −0.39, p < 0.01), and accurately differentiated cognitive impairment (area under the curve 0.94, 95% CI 0.88–0.99). DISCUSSION This level of undiagnosed cognitive impairment and AD pathology exceeds what would be expected in the general population and highlights a potential need for screening and future work to better identify treatment options. Highlights Brain health outcomes are rarely evaluated in vascular patients. One hundred sixty‐two adults with asymptomatic cardiovascular disease but without diagnoses of cognitive impairment or dementia were evaluated. Phosphorylated tau217 accurately differentiated cognitive impairment in patients with cardiovascular disease. High levels of cognitive impairment and Alzheimer's disease pathology are greatly underdiagnosed in the cardiovascular population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive Dysfunctiontau ProteinsAlzheimer DiseaseCardiovascular DiseasesHumansFemaleMaleAgedBiomarkersCohort StudiesMental Status and Dementia TestsProspective StudiesPhosphorylationMiddle AgedAged, 80 and overNeuropsychological Tests

Stichwörter der Autor:innen

Alzheimer's diseaseblood biomarkerscognitive impairmentvascular diseasevascular risk factors

Substanzen

tau ProteinsBiomarkers

Autor:innen und Institutionen

  • The Division of Vascular Surgery, University of Arizona, Tucson, Arizona, USA.
  • Department of Psychology, University of Arizona, Tucson, Arizona, USA.
  • Department of Medical Imaging, University of Arizona, Tucson, Arizona, USA.
  • Pima Heart and Vascular, Tucson, Arizona, USA.
  • Department of Cardiovascular Medicine, Sarver Heart Center, University of Arizona College of Medicine, Tucson, Arizona, USA.
  • Department of Neurology, University of Arizona, Tucson, Arizona, USA.

ORCID-Profile: Scott R French, Craig C Weinkauf

Förderung

  • Health Sciences, University of Arizona
  • U24 AG082930 Alzheimer Diagnosis in older Adults with Chronic Conditions ADACC Network
  • NIA NIH HHS
  • Doris Duke Foundation
  • Arizona Biomedical Research Commission
  • University of Arizona Health Sciences Career Development Award
  • NHLBI NIH HHS
  • Doris Duke Charitable Foundation

Zitieren

APA

French, S. R., Arias, J. C., Zahra, S., Ally, M., Escareno, C., Heitkamp, E., Vazquez, F., Hillis, M., Wiskoski, H., Ainapurapu, K., Culwell, G., Howell, C., Johnson, K., Kraemer, C., Pacanowski, J., Leon, L., Berman, S., Yanquez, F., Balderman, J., …, & Weinkauf, C. C. (2025). Cognitive impairment and p‐tau217 are high in a vascular patient cohort. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70565

Vancouver

French SR, Arias JC, Zahra S, Ally M, Escareno C, Heitkamp E, et al. Cognitive impairment and p‐tau217 are high in a vascular patient cohort. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70565

BibTeX
@article{French2025,
  author = {French, Scott R and Arias, Juan C and Zahra, Summan and Ally, Madeline and Escareno, Cris and Heitkamp, Emma and Vazquez, Franchell and Hillis, Madison and Wiskoski, Haley and Ainapurapu, Karthik and Culwell, Gavin and Howell, Caronae and Johnson, Kevin and Kraemer, Cody and Pacanowski, John and Leon, Luis and Berman, Scott and Yanquez, Federico and Balderman, Joshua and Sabat, Joseph and Hung, Olivia and Lucas, Layla and Vitali, Francesca and Bedrick, Edward J and Mushtaq, Raza and Altbach, Maria and Trouard, Theodore P and Elahi, Fanny M and Ashton, Nicholas J and Dage, Jeffrey L and Reiman, Eric M and Alexander, Gene E and Weinkauf, Craig C},
  title = {Cognitive impairment and p‐tau217 are high in a vascular patient cohort},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  doi = {10.1002/alz.70565}
}
Kostenlos starten →